Next Article in Journal
Genetic Heterogeneity, Therapeutic Hurdle Confronting Sorafenib and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
Next Article in Special Issue
Immune Checkpoint Inhibitors in Urothelial Bladder Cancer: State of the Art and Future Perspectives
Previous Article in Journal
Host–Microbiota Interactions in Liver Inflammation and Cancer
Previous Article in Special Issue
Immune Checkpoint Inhibition in Advanced Non-Clear Cell Renal Cell Carcinoma: Leveraging Success from Clear Cell Histology into New Opportunities
 
 
Review

Article Versions Notes

Cancers 2021, 13(17), 4341; https://doi.org/10.3390/cancers13174341
Action Date Notes Link
article xml file uploaded 27 August 2021 14:49 CEST Original file -
article xml uploaded. 27 August 2021 14:49 CEST Update https://www.mdpi.com/2072-6694/13/17/4341/xml
article pdf uploaded. 27 August 2021 14:49 CEST Version of Record https://www.mdpi.com/2072-6694/13/17/4341/pdf
article html file updated 27 August 2021 14:50 CEST Original file -
article html file updated 30 July 2022 03:02 CEST Update https://www.mdpi.com/2072-6694/13/17/4341/html
Back to TopTop